ArticleDiabetology & metabolic syndrome2016

Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure.

David Nathanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.